Similarly, in a murine model of Parkinson’s disease, EGCG was found to reduce the expression of mTOR, Akt, and glycogen synthase kinase-3 beta (GSK-3β) and inhibit neuronal apoptosis [88]. Here, GSK3B is linked to Parkinson disease.